VARIANTS AND EXONS OF THE GLYT1 TRANSPORTER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080201789A1
SERIAL NO

12050255

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides polypeptide and polynucleotide sequences for novel splice variants of the sodium and chloride-dependent glycine transporter type 1 (GlyT1). These polypeptides and polynucleotides are useful in the treatment and diagnosis of disorders such as neurological and psychiatric disorders including schizophrenia. The invention also provides antibodies directed specifically against these novel polypeptides, and kits comprising the herein-described polynucleotides, polypeptides, and/or antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SERONO BIODEVELOPMENT69008 LYON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Grel, Pascale Viry-Chatillon, FR 4 0
Jais, Philippe Issy-les-Moylineaux, FR 6 13
Mace, Sandrine Jouy-en-Josas, FR 18 19
Thill, Gilbert Bois Colombes, FR 4 69

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation